BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $599 | -25.5% | 15,868 | -9.7% | 0.52% | -19.9% |
| Q2 2023 | $804 | +8.8% | 17,564 | -3.4% | 0.65% | +5.0% |
| Q1 2023 | $739 | -24.8% | 18,180 | -5.9% | 0.62% | -25.3% |
| Q4 2022 | $983 | -99.9% | 19,314 | -4.6% | 0.83% | -8.5% |
| Q3 2022 | $1,093,000 | -14.9% | 20,248 | +0.9% | 0.90% | -16.3% |
| Q2 2022 | $1,285,000 | -18.0% | 20,063 | -0.9% | 1.08% | +19.0% |
| Q1 2022 | $1,567,000 | -5.5% | 20,247 | +4.9% | 0.91% | -2.5% |
| Q4 2021 | $1,658,000 | +25.0% | 19,302 | +16.7% | 0.93% | +4.4% |
| Q3 2021 | $1,326,000 | +0.3% | 16,543 | +0.6% | 0.89% | +1.2% |
| Q2 2021 | $1,322,000 | -21.0% | 16,446 | -16.9% | 0.88% | +408.7% |
| Q1 2021 | $1,674,000 | +8.0% | 19,791 | +2.3% | 0.17% | +5.5% |
| Q4 2020 | $1,550,000 | +1.8% | 19,354 | +2.0% | 0.16% | -4.1% |
| Q3 2020 | $1,522,000 | -8.2% | 18,976 | -1.6% | 0.17% | -20.5% |
| Q2 2020 | $1,658,000 | -3.8% | 19,281 | -9.1% | 0.22% | -21.0% |
| Q1 2020 | $1,724,000 | -28.3% | 21,207 | -26.4% | 0.27% | -14.7% |
| Q4 2019 | $2,404,000 | -58.2% | 28,823 | -56.4% | 0.32% | -60.3% |
| Q3 2019 | $5,757,000 | -19.0% | 66,057 | -23.9% | 0.80% | -2.3% |
| Q2 2019 | $7,105,000 | -5.3% | 86,773 | -7.0% | 0.82% | -16.4% |
| Q1 2019 | $7,506,000 | +6.3% | 93,302 | -13.5% | 0.98% | +13.9% |
| Q4 2018 | $7,062,000 | -7.3% | 107,912 | +9.0% | 0.86% | +3.5% |
| Q3 2018 | $7,615,000 | +18.9% | 98,994 | +14.2% | 0.83% | +2.2% |
| Q2 2018 | $6,402,000 | +41.9% | 86,698 | +24.6% | 0.82% | +50.0% |
| Q1 2018 | $4,513,000 | -3.9% | 69,590 | -4.3% | 0.54% | -9.8% |
| Q4 2017 | $4,697,000 | – | 72,684 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |